CHM chimeric therapeutics limited

0.00%

0.4¢

Sorry, Dalts, you beat me to the post! LOL "Pipped at the Post"

First 598 Last

Share
Profile

Follow
Shellbell

8,333 Posts.

3663

16/02/24

10:49

Post #: 72439323
Share

Originally posted by dalts66: ↑

This is a fair pick up. i was in a bit of a rush and didnt correctly describe this.

Normal GBM survival from being diagnosed is 12 to 18 months. This is a very aggressive disease. Normal life expectancy after the first line of treatment with SOC is 6 to 7 months. CHM have statistically longer survival rate than compared to SOC, even when used as the 4th line of treatment.

The announcement referred to above is a good source as is the investor presentation.

This is why, if these results can be replicated, CHM will be well placed for the planned accelerated approval pathway. As a 4th line treatment they have already outperformed the FDA approved SOC drugs (see announcement mentioned above and investor presentation).

To ensure the accelerated approval trial happens, and happens in a way that a small drug discovery biotechnology company like CHM can afford and manage, we need experienced people at the wheel. And CHM has that. It has the people that developed the first CarT drugs, and guided those trials through the FDA approval process (their employment history is available on the CHM website). That experience comes at a price. But that experience also has a large part in success or failure of the drug development and approval.So, as stated before, its money well spent.

Expand

Sorry, Dalts, you beat me to the post! LOL "Pipped at the Post"

Last edited by Shellbell: 16/02/24

CHM Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

PIQ

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

First 598 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $8.060M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$28.14K	7.037M

Buyers (Bids)

No.	Vol.	Price($)
1	243067	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	14771167	22

View Market Depth

No.	Vol.	Price($)
1	243067	0.004
41	26897271	0.003
15	13950505	0.002
10	50600000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	14771167	22
0.006	13197211	14
0.007	3200000	3
0.008	8542434	6
0.009	2327672	4

Last trade - 15.39pm 20/06/2025 (20 minute delay)

CHM (ASX) Chart

Sorry, Dalts, you beat me to the post! LOL "Pipped at the Post"

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sorry, Dalts, you beat me to the post! LOL "Pipped at the Post"

Top Stories

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News